FALOPPI, LUCA
FALOPPI, LUCA
MULTICENTER PROSPECTIVE STUDY OF ANGIOGENESIS POLYMORPHISM VALIDATION IN HCC PATIENTS TREATED WITH SORAFENIB: THE INNOVATE STUDY
2019-06-10
Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma
2017-01-01 De Matteis, Serena; Granato, Anna Maria; Napolitano, Roberta; Molinari, Chiara; Valgiusti, Martina; Santini, Daniele; Foschi, Francesco Giuseppe; Ercolani, Giorgio; Vespasiani Gentilucci, Umberto; Faloppi, Luca; Scartozzi, Mario; Frassineti, Giovanni Luca; Casadei Gardini, Andrea
Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale
2017-01-01 Casadei Gardini, Andrea; Faloppi, Luca; De Matteis, Serena; Foschi, Francesco Giuseppe; Silvestris, Nicola; Tovoli, Francesco; Palmieri, Vincenzo; Marisi, Giorgia; Brunetti, Oronzo; Vespasiani gentilucci, Umberto; Perrone, Giuseppe; Valgiusti, Martina; Granato, Anna Maria; Ercolani, Giorgio; Negrini, Giulia; Tamburini, Emiliano; Aprile, Giuseppe; Passardi, Alessandro; Santini, Daniele; Cascinu, Stefano; Frassineti, Giovanni Luca; Scartozzi, Mario
Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: A retrospective study
2017-01-01 Gardini, Andrea Casadei; Foca, Flavia; Scartozzi, Mario; Silvestris, Nicola; Tamburini, Emiliano; Faloppi, Luca; Brunetti, Oronzo; Rudnas, Britt; Pisconti, Salvatore; Valgiusti, Martina; Marisi, Giorgia; Foschi, Francesco Giuseppe; Ercolani, Giorgio; Tassinari, Davide; Cascinu, Stefano; Frassineti, Giovanni Luca
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy
2017-01-01 Giampieri, Riccardo; Maccaroni, Elena; Mandolesi, Alessandra; Del Prete, Michela; Andrikou, Kalliopi; Faloppi, Luca; Bittoni, Alessandro; Bianconi, Maristella; Scarpelli, Marina; Bracci, Raffaella; Scartozzi, Mario; Cascinu, Stefano
Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma
2017-01-01 Di Costanzo, Giovan Giuseppe; Casadei Gardini, Andrea; Marisi, Giorgia; Foschi, Francesco Giuseppe; Scartozzi, Mario; Granata, Rocco; Faloppi, Luca; Cascinu, Stefano; Silvestris, Nicola; Brunetti, Oronzo; Palmieri, Vincenzo Ostilio; Ercolani, Giorgio; Tortora, Raffaella
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients
2016-01-01 Giampieri, R; Salvatore, L; Del Prete, M; Prochilo, T; D'Anzeo, M; Loretelli, C; Loupakis, F; Aprile, G; Maccaroni, E; Andrikou, K; Bianconi, M; Bittoni, A; Faloppi, Luca; Demurtas, Laura; Montironi, R; Scarpelli, M; Falcone, A; Zaniboni, A; Scartozzi, Mario; Cascinu, S.
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma
2016-01-01 Bianconi, M; Faloppi, Luca; Loretelli, C; Zizzi, A; Giampieri, R; Bittoni, A; Andrikou, K; Del Prete, M; Burattini, L; Montironi, R; Scartozzi, Mario; Cascinu, S.
Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced hcc patients treated with sorafenib: results from a retrospective analysis of the HCC-AVR group
2016-01-01 Casadei Gardini, A; Scarpi, E; Marisi, G; Foschi, Fg; Donati, G; Giampalma, E; Faloppi, Luca; Scartozzi, Mario; Silvestris, N; Bisulli, M; Corbelli, J; Gardini, A; La Barba, G; Veneroni, L; Tamberi, S; Cascinu, S; Frassineti, Gl
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS study
2016-01-01 Gardini, Andrea Casadei; Marisi, Giorgia; Faloppi, Luca; Scarpi, Emanuela; Foschi, Francesco Giuseppe; Iavarone, Massimo; Lauletta, Gianfranco; Corbelli, Jody; Valgiusti, Martina; Facchetti, Floriana; della Corte, Cristina; Neri, Luca Maria; Tamberi, Stefano; Cascinu, Stefano; Scartozzi, Mario; Amadori, Dino; Nanni, Oriana; Tenti, Elena; Ulivi, Paola; Frassineti, Giovanni Luca
Lactate dehydrogenase in hepatocellular carcinoma: something old, something new
2016-01-01 Faloppi, Luca; Bianconi, M; Memeo, R; Casadei Gardini, A; Giampieri, R; Bittoni, A; Andrikou, K; Del Prete, M; Cascinu, S; Scartozzi, Mario
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy
2016-01-01 Faloppi, Luca; Del Prete, M; Casadei Gardini, A; Santini, D; Silvestris, N; Bianconi, M; Giampieri, R; Valgiusti, M; Brunetti, O; Bittoni, A; Andrikou, K; Lai, ELEONORA VERONICA; Dessi', Alessandra; Cascinu, S; Scartozzi, Mario
The immune revolution in gastrointestinal tumours: leading the way or just following?
2016-01-01 Puzzoni, Marco; Silvestris, N; Leone, F; Giampieri, R; Faloppi, Luca; Demurtas, Laura; Dell’Aquila, E; Marino, D; Brunetti, O; Garattini, Sk; Ongaro, E; Astara, G; Orgiano, Laura; Aprile, G; Santini, D; Scartozzi, Mario
Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib
2015-01-01 Casadei Gardini, A; Marisi, G; Scarpi, E; Scartozzi, Mario; Faloppi, Luca; Silvestris, N; Masi, G; Vivaldi, C; Brunetti, O; Tamberi, S; Foschi, Fg; Tamburini, E; Tenti, E; Ricca Rosellini, S; Ulivi, P; Cascinu, S; Nanni, O; Frassineti, Gl
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab
2015-01-01 Giampieri, R; Mandolesi, A; Abouelkhair, Km; Loretelli, C; Del Prete, M; Faloppi, Luca; Maristella, B; Ibrahim, Em; Scarpelli, M; Cascinu, S; Scartozzi, Mario
Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology
2015-01-01 Aprile, Giuseppe; Leone, Francesco; Giampieri, Riccardo; Casagrande, Mariaelena; Marino, Donatella; Faloppi, Luca; Cascinu, Stefano; Fasola, Gianpiero; Scartozzi, Mario
| Titolo | Data di pubblicazione | Autore(i) | Rivista | Editore |
|---|---|---|---|---|
| MULTICENTER PROSPECTIVE STUDY OF ANGIOGENESIS POLYMORPHISM VALIDATION IN HCC PATIENTS TREATED WITH SORAFENIB: THE INNOVATE STUDY | 10-giu-2019 | - | - | Università degli Studi di Cagliari |
| Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma | 1-gen-2017 | De Matteis, Serena; Granato, Anna Maria; Napolitano, Roberta; Molinari, Chiara; Valgiusti, Martina; Santini, Daniele; Foschi, Francesco Giuseppe; Ercolani, Giorgio; Vespasiani Gentilucci, Umberto; Faloppi, Luca; Scartozzi, Mario; Frassineti, Giovanni Luca; Casadei Gardini, Andrea | DIGESTIVE DISEASES AND SCIENCES | - |
| Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale | 1-gen-2017 | Casadei Gardini, Andrea; Faloppi, Luca; De Matteis, Serena; Foschi, Francesco Giuseppe; Silvestris, Nicola; Tovoli, Francesco; Palmieri, Vincenzo; Marisi, Giorgia; Brunetti, Oronzo; Vespasiani gentilucci, Umberto; Perrone, Giuseppe; Valgiusti, Martina; Granato, Anna Maria; Ercolani, Giorgio; Negrini, Giulia; Tamburini, Emiliano; Aprile, Giuseppe; Passardi, Alessandro; Santini, Daniele; Cascinu, Stefano; Frassineti, Giovanni Luca; Scartozzi, Mario | EUROPEAN JOURNAL OF CANCER | - |
| Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: A retrospective study | 1-gen-2017 | Gardini, Andrea Casadei; Foca, Flavia; Scartozzi, Mario; Silvestris, Nicola; Tamburini, Emiliano; Faloppi, Luca; Brunetti, Oronzo; Rudnas, Britt; Pisconti, Salvatore; Valgiusti, Martina; Marisi, Giorgia; Foschi, Francesco Giuseppe; Ercolani, Giorgio; Tassinari, Davide; Cascinu, Stefano; Frassineti, Giovanni Luca | SCIENTIFIC REPORTS | - |
| Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy | 1-gen-2017 | Giampieri, Riccardo; Maccaroni, Elena; Mandolesi, Alessandra; Del Prete, Michela; Andrikou, Kalliopi; Faloppi, Luca; Bittoni, Alessandro; Bianconi, Maristella; Scarpelli, Marina; Bracci, Raffaella; Scartozzi, Mario; Cascinu, Stefano | GASTRIC CANCER | - |
| Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma | 1-gen-2017 | Di Costanzo, Giovan Giuseppe; Casadei Gardini, Andrea; Marisi, Giorgia; Foschi, Francesco Giuseppe; Scartozzi, Mario; Granata, Rocco; Faloppi, Luca; Cascinu, Stefano; Silvestris, Nicola; Brunetti, Oronzo; Palmieri, Vincenzo Ostilio; Ercolani, Giorgio; Tortora, Raffaella | TARGETED ONCOLOGY | - |
| Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients | 1-gen-2016 | Giampieri, R; Salvatore, L; Del Prete, M; Prochilo, T; D'Anzeo, M; Loretelli, C; Loupakis, F; Aprile, G; Maccaroni, E; Andrikou, K; Bianconi, M; Bittoni, A; Faloppi, Luca; Demurtas, Laura; Montironi, R; Scarpelli, M; Falcone, A; Zaniboni, A; Scartozzi, Mario; Cascinu, S. | SCIENTIFIC REPORTS | - |
| Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma | 1-gen-2016 | Bianconi, M; Faloppi, Luca; Loretelli, C; Zizzi, A; Giampieri, R; Bittoni, A; Andrikou, K; Del Prete, M; Burattini, L; Montironi, R; Scartozzi, Mario; Cascinu, S. | ONCOTARGET | - |
| Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced hcc patients treated with sorafenib: results from a retrospective analysis of the HCC-AVR group | 1-gen-2016 | Casadei Gardini, A; Scarpi, E; Marisi, G; Foschi, Fg; Donati, G; Giampalma, E; Faloppi, Luca; Scartozzi, Mario; Silvestris, N; Bisulli, M; Corbelli, J; Gardini, A; La Barba, G; Veneroni, L; Tamberi, S; Cascinu, S; Frassineti, Gl | ONCOTARGET | - |
| eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS study | 1-gen-2016 | Gardini, Andrea Casadei; Marisi, Giorgia; Faloppi, Luca; Scarpi, Emanuela; Foschi, Francesco Giuseppe; Iavarone, Massimo; Lauletta, Gianfranco; Corbelli, Jody; Valgiusti, Martina; Facchetti, Floriana; della Corte, Cristina; Neri, Luca Maria; Tamberi, Stefano; Cascinu, Stefano; Scartozzi, Mario; Amadori, Dino; Nanni, Oriana; Tenti, Elena; Ulivi, Paola; Frassineti, Giovanni Luca | ONCOTARGET | - |
| Lactate dehydrogenase in hepatocellular carcinoma: something old, something new | 1-gen-2016 | Faloppi, Luca; Bianconi, M; Memeo, R; Casadei Gardini, A; Giampieri, R; Bittoni, A; Andrikou, K; Del Prete, M; Cascinu, S; Scartozzi, Mario | BIOMED RESEARCH INTERNATIONAL | - |
| The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy | 1-gen-2016 | Faloppi, Luca; Del Prete, M; Casadei Gardini, A; Santini, D; Silvestris, N; Bianconi, M; Giampieri, R; Valgiusti, M; Brunetti, O; Bittoni, A; Andrikou, K; Lai, ELEONORA VERONICA; Dessi', Alessandra; Cascinu, S; Scartozzi, Mario | SCIENTIFIC REPORTS | - |
| The immune revolution in gastrointestinal tumours: leading the way or just following? | 1-gen-2016 | Puzzoni, Marco; Silvestris, N; Leone, F; Giampieri, R; Faloppi, Luca; Demurtas, Laura; Dell’Aquila, E; Marino, D; Brunetti, O; Garattini, Sk; Ongaro, E; Astara, G; Orgiano, Laura; Aprile, G; Santini, D; Scartozzi, Mario | TARGETED ONCOLOGY | - |
| Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib | 1-gen-2015 | Casadei Gardini, A; Marisi, G; Scarpi, E; Scartozzi, Mario; Faloppi, Luca; Silvestris, N; Masi, G; Vivaldi, C; Brunetti, O; Tamberi, S; Foschi, Fg; Tamburini, E; Tenti, E; Ricca Rosellini, S; Ulivi, P; Cascinu, S; Nanni, O; Frassineti, Gl | EXPERT OPINION ON PHARMACOTHERAPY | - |
| Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab | 1-gen-2015 | Giampieri, R; Mandolesi, A; Abouelkhair, Km; Loretelli, C; Del Prete, M; Faloppi, Luca; Maristella, B; Ibrahim, Em; Scarpelli, M; Cascinu, S; Scartozzi, Mario | JOURNAL OF TRANSLATIONAL MEDICINE | - |
| Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology | 1-gen-2015 | Aprile, Giuseppe; Leone, Francesco; Giampieri, Riccardo; Casagrande, Mariaelena; Marino, Donatella; Faloppi, Luca; Cascinu, Stefano; Fasola, Gianpiero; Scartozzi, Mario | ONCOTARGETS AND THERAPY | - |